WithdrawnNot Applicable

Evaluating the Role of the Guidewire in Peripheral Intravenous Access

Stopped: Protocol was substantially revised

United States0Started 2023-12

Plain-language summary

This study is to demonstrate that the control ultralong intravenous catheter without the guide wire is equivalent to the experimental catheter with the guide wire. The hypothesis of this study is that the 6.35 cm 20G ultralong Ultrasound Guided Peripheral Intravenous (USPIV) will have no difference in survival compared to the 5.71 cm ultralong with wire USPIV.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Eligible patients must be: 1. ≥ than 18 years old 2. Vascular Access Score 4 or 5. Clinicians Eligibility Criteria: 1. Clinician working in the emergency room (physician, advanced practice provider, nurse, technician) OR clinician working on the inpatient vascular access team (advanced practice provider, nurse) 2. Greater than 6 months experience in ultrasound guided IV insertions Patients are excluded: 1. \<18 years old 2. Restricted mobility of elbow joint 3. Cognitively impaired

What they're measuring

Catheter survival

Timeframe: During hospitalization, up to 60 days

Trial details

NCT IDNCT04949854

SponsorCorewell Health East

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-12

View on ClinicalTrials.gov More Peripheral Intravenous Vein Catheter Phlebitis trials